Scientists, including one of Indian-origin, have developed a nanotechnology-based test that can quickly detect the presence of the Zika virus in the blood, an advance that may also be applicable to other emerging infectious diseases.
Currently, testing for Zika requires that a blood sample be refrigerated and shipped to a medical centre or laboratory, delaying diagnosis and possible treatment.
The new test, however, relies on a protein made by the Zika virus that causes an immune response in infected individuals, which is then attached to tiny gold nanorods mounted on a piece of paper.
The paper then is completely covered with tiny, protective nanocrystals. The nanocrystals allow the diagnostic nanorods to be shipped and stored without refrigeration prior to use, the researchers said.
"If an assay requires electricity and refrigeration, it defeats the purpose of developing something to use in a resource-limited setting, especially in tropical areas of the world," said Srikanth Singamaneni, Associate Professor at the Washington University in St. Louis.
"We wanted to make the test immune from variations in temperature and humidity," Singamaneni added.
When a drop of the patient's blood is applied on the paper mounted on the nanorods, the immunoglobulins in the blood will react with the protein if the patient has come into contact with the virus and demonstrate a colour change.
"The immunoglobulins persist in the blood for a few months, and when they come into contact with the gold nanorods, the nanorods undergo a slight colour change that can be detected with a hand-held spectrophotometer," explained Jeremiah J. Morrissey, Professor at the varsity.
"With this test, results will be clear before the patient leaves the clinic, allowing immediate counselling and access to treatment," he added in the paper detailed in the journal Advanced Biosystems.
As other infectious diseases emerge around the world, similar strategies potentially could be used to develop tests to detect the presence of viruses that may become problematic, the researchers said.
--IANS
rt/amit/bg
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
